Apoptosis and growth inhibition of head and neck tumor cell line induced by epidermal growth factor receptor tyrosine kinase inhibitor

Oral Oncology

Volumn 35, Issue 3, 1999, Pages 290-295

  Faust, R A ^a   Tawfic, S ^b,c   Davis, A T ^c   Ahmed, K ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Autocrine; Cancer treatment; Cell signalling; Growth factor; Kinase; Receptor

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; DNA NUCLEOTIDYLEXOTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CYTOSTASIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GINGIVA; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ENZYME INHIBITORS; GINGIVAL NEOPLASMS; HUMANS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0032978037     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00118-3     Document Type: Article

References (30)

1. Shin D.M., Ro J.Y., Hong W.K., Hittelman W.N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Research. 54:1984;3153-3159.
2. Santini J., Formento J.L., Francoual M., Milano G, Schneider M, Dassonville O, Demard F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head and Neck. 13:1991;132-139.
3. Grandis J.R., Tweardy D.J. Elevated levels of transforming growth factor (alpha) and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Research. 53:1993;3579-3584.
4. Ozawa S., Ueda M., Ando N., Shimizu N., Abe O. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer. 63:1989;2169-2173.
5. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annual Review of Biochemistry. 56:1987;881-914.
6. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
7. Cohen S. The epidermal growth factor. Cancer. 51:1983;1787-1791.
8. Bishop J.M. The molecular genetics of cancer. Science. 235:1987;305-311.
9. Riedel H., Massoglia J., Schlessinger J., Ullrich A. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. Proceedings of the National Academy of Sciences, USA. 85:1988;1477-1488.
10. Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., Lee D.C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carinoma of the breast. Cell. 61:1990;1121-1135.
11. Jhappan C., Stahle C., Harkins R.N., Fausto N., Smith G.F., Merlino G.T. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 61:1990;1137-1146.
12. Aaronson S.A. Growth factors and cancer. Science. 245:1991;1146-1153.
13. Modjtahedi H., Dean C. The receptor for EGF and its ligands: expression, prognostic value and target for therapy in cancer. International Journal of Oncology. 4:1994;277-296.
14. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 267:1995;1782-1788.
15. Fry D.W., Kraker A.J., McMichael A., Ambroso L.A., Nelson J.M., Leopold W.R., Conners R.W., Bridges A.J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 265:1994;1093-1095.
16. Yamamoto T., Kamata N., Kawano H., Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gaman S, Shimizu N. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Research. 46:1986;414-416.
17. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. Journal of Cell Biology. 71:1976;159-171.
18. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology. 119:1992;493-501.
19. Zar J.H. Biostatistical Analysis. Englewood Cliffs: Prentice Hall, 1984.
20. Sporn M.B., Todaro G.J. Autocrine secretion and malignant transformation of cells. New England Journal of Medicine. 303:1980;878-880.
21. Majno G., Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. American Journal of Pathology. 146:1995;3-15.
22. Oren M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Review. 11:1992;141-148.
23. Pardee A.B. Molecules involved in proliferation of normal and cancer cells: presidential address. Cancer Reseach. 47:1987;1488-1491.
24. Grandis J.R., Tweardy D.J. The role of peptide growth factors in head and neck carcinoma. Otolaryngologic Clinics of North America. 25:1992;1105-1115.
25. Yoshida T., Satoh M., Nakagaito Y., Kuno H, Takeuchi M. Cytokines affecting survival and differentiation of astrocyte progenitor cell line. Developmental Brain Research. 76:1993;147-150.
26. Luciano A.M., Pappalardo A., Ray C., Peluso J.J. Epidermal growth factor inhibits large granulosa cell apoptosis by stimulating progesterone synthesis and regulating the distribution of intracellular free calcium. Biology of Reproduction. 51:1994;646-654.
27. Slaughter D.L., Southwick H.W., Smejkal W. "Field cancerization" in oral stratefied squamous epithelium: clinical implication of multicentric origin. Cancer. 6:1953;963-968.
28. Brachman D.G. Molecular biology of head and neck cancer. Seminars in Oncology. 21:1994;320-329.
29. Jares P., Fernandez P.L., Campo E., Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A. PRAD1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Research. 54:1994;4813-4817.
30. Gapany M., Faust R.A., Tawfic S., Davis A., Adams G.L., Ahmed K. Association of protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Molecular Medicine. 1:1995;659-666.